119 related articles for article (PubMed ID: 7915507)
41. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
42. [Functional morphology of nuclear organizer regions of chromosomes and of nucleoli in cells of human multiple myeloma cell lines. II.Relationship between immunoglobulin E production and argentophilia of nuclear organizer regions of chromosomes in U 266 cell line].
Turilova VI; Smirnova TD; Samoĭlovich MP; Sukhikh TR
Tsitologiia; 1999; 41(10):857-63. PubMed ID: 10591123
[TBL] [Abstract][Full Text] [Related]
43. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in salivary gland mucoepidermoid carcinoma and its relation to histological grade.
Alaeddini M; Khalili M; Tirgary F; Etemad-Moghadam S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):758-62. PubMed ID: 18299224
[TBL] [Abstract][Full Text] [Related]
44. AgNOR pattern and PCNA analysis in fine needle biopsies of liver cell carcinoma.
Valenca JT; Escanhoel CA; Metze K
Neoplasma; 2001; 48(5):370-3. PubMed ID: 11845981
[TBL] [Abstract][Full Text] [Related]
45. Villous cytotrophoblast proliferating potential in complete and partial hydatidiform mole: diagnostic value of silver-stained nucleolar organizer region (AgNOR)-associated proteins.
Neudeck H; Unger M; Hufnagl P; Eiben B; Peters K; Kalla J; Graf R; Vogel M
Gen Diagn Pathol; 1997 Nov; 143(2-3):179-84. PubMed ID: 9443574
[TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
[TBL] [Abstract][Full Text] [Related]
47. [Nucleolus organizer regions in benign and malignant diseases of the exocrine pancreas--comparison with an analysis of the proliferation marker PCNA].
Reich O; Heinisch G; Justus J
Pathologe; 1993 Jan; 14(1):1-6. PubMed ID: 8095718
[No Abstract] [Full Text] [Related]
48. [Quantification of nucleolar organizers (NORs) in renal carcinomas. Comparison with the nuclear grade].
Serre I; Vieillefond A; Schovaert D; Quillard J; Benoit G; Martin E
Prog Urol; 1992 Apr; 2(2):196-206. PubMed ID: 1302055
[TBL] [Abstract][Full Text] [Related]
49. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma].
Hahn J; Linhart W; Müller H; Renz S; Schneider M
Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598
[TBL] [Abstract][Full Text] [Related]
50. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells.
Derenzini M; Pession A; Trerè D
Lab Invest; 1990 Jul; 63(1):137-40. PubMed ID: 1695695
[TBL] [Abstract][Full Text] [Related]
51. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
[TBL] [Abstract][Full Text] [Related]
52. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
53. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
54. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.
Pich A; Chiusa L; Pisani P; Krengli M; Pia F; Navone R
J Cancer Res Clin Oncol; 1992; 119(2):106-10. PubMed ID: 1358893
[TBL] [Abstract][Full Text] [Related]
55. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
[TBL] [Abstract][Full Text] [Related]
56. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
57. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.
Crocker J; Egan MJ
J Pathol; 1988 Nov; 156(3):233-9. PubMed ID: 3060577
[TBL] [Abstract][Full Text] [Related]
58. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
[TBL] [Abstract][Full Text] [Related]
59. Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions.
Tateyama H; Mizuno T; Tada T; Eimoto T; Hashimoto T; Masaoka A
Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):265-9. PubMed ID: 8099456
[TBL] [Abstract][Full Text] [Related]
60. Proliferative activity in peripheral ossifying fibroma and ossifying fibroma.
Mesquita RA; Orsini SC; Sousa M; de Araújo NS
J Oral Pathol Med; 1998 Feb; 27(2):64-7. PubMed ID: 9526731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
